After-Hours Movers 7/29: Elan (ELN) Falls On Drug Data, MetLife (MET) Falls On Earnings/Guidance

July 29, 2008 6:13 PM EDT

StreetInsider.com After-Hours Movers:

Denny's Corporation (Nasdaq: DENN) 18% HIGHER; reports Q2 EPS of $0.30, which may not compare to the analyst estimate of $0.04. Revenues for the quarter were $190.3 million, versus the consensus of $188.57 million. Raises adjusted income guidance to $13-$17 million.

Hanesbrands (NYSE: HBI) 17% LOWER; reports Q2 EPS of $0.69, 1 cent better than the analyst estimate of $0.68. Revenues for the quarter were $1.08 billion, versus the consensus of $1.10 billion.

Elan Corp (NYSE: ELN) 16% LOWER; reports trial data on Bapineuzumab for Alzheimer's.

RadiSys Corporation (Nasdaq: RSYS) 16% HIGHER; reports Q2 EPS of $0.14, 8 cents better than the analyst estimate of $0.06. Revenues for the quarter were $97.6 million, versus the consensus of $87.75 million. Sees Q3 eps 16-22 cents versus 9 cents. Sees Q3 revs $98-$103 million versus $91 million.

Align Technology (Nasdaq: ALGN) 15% LOWER; reports Q2 EPS of $0.06, 1 cents better than the analyst estimate of $0.05. Revenues for the quarter were $79.9 million, versus the consensus of $79.67 million. Sees Q3 EPS of $0.04-$0.06, versus the consensus of $0.11. Sees 2008 EPS of $0.29-$0.33, versus the consensus of $0.40.

Starent Networks Corporation (Nasdaq: STAR) 15% HIGHER; reports Q2 EPS of $0.14, 3 cents lower than the analyst estimate of $0.17. Revenues for the quarter were $61.2 million, versus the consensus of $57.85 million. Says court granted motion to dismiss 10 claims in UTStarcom suit.

Buffalo Wild Wings, Inc. (Nasdaq: BWLD) 14% HIGHER; reports Q2 EPS of $0.31, 4 cents better than the analyst estimate of $0.27. Revenues for the quarter were $97.9 million, versus the consensus of $94.62 million.

OfficeMax (NYSE: OMX) 14% LOWER; reports Q2 EPS of $0.24, ex-items, 6 cents better than the analyst estimate of $0.18. Revenues for the quarter were $1.98 billion, versus the consensus of $2.02 billion.

CB Richard Ellis Group, Inc. (NYSE: CBG) 12% LOWER; reports Q2 EPS of $0.16, 28 cents below the analyst estimate of $0.44. Revenues for the quarter were $1.3 billion, versus the consensus of $1.42 billion.

Cardiac Science (Nasdaq: CSCX) 11.5% HIGHER; reports Q2 EPS of $0.10, 1 cent better than the analyst estimate of $0.09. Revenues for the quarter were $52.1 million, versus the consensus of $49.90 million. Sees FY08 revs of $205-$210 million, versus the consensus of $203.5 million and EPS in the range of $0.38-$0.41, versus prior guidance of $0.34-$0.39, versus the consensus of $0.39.

MetLife, Inc. (NYSE: MET) 10% LOWER; reports Q2 EPS of $1.30, versus the analyst estimate of $1.51. Revenues for the quarter were $13.7 billion, versus the consensus of $13.89 billion. Lowers its FY08 EPS guidance from $5.90-$6.20 to $5.70-$5.90, versus the consensus of $6.15.

LECG Corp (Nasdaq: XPRT) 10% LOWER; reports Q2 EPS of $0.10, 11 cents below the analyst estimate of $0.21. Revenues for the quarter were $89.1 million, versus the consensus of $98.09 million.

Wyeth (NYSE: WYE) 8% LOWER; reports trial data on Bapineuzumab for Alzheimer's.

RF Micro Devices, Inc. (Nasdaq: RFMD) 7.9% HIGHER; reports Q2 EPS of $0.03, 2 cents better than the analyst estimate of $0.01. Revenues for the quarter were $240.5 million, versus the consensus of $236.88 million. Sees Q3 revs $250-$260 million versus $255 million

HealthSpring, Inc. (NYSE: HS) 7.8% HIGHER; reports Q2 EPS of $0.72, which may not compare to the analyst estimate of $0.44. Revenues for the quarter were $554 million, versus the consensus of $528.31 million. Sees FY08 EPS of $2.05-$2.15, versus the consensus of $1.89.

VNUS Medical Technologies (Nasdaq: VNUS) 7% LOWER; reports Q2 EPS of $0.56, versus the analyst estimate of $0.56. Revenues for the quarter were $31.9 million, versus the consensus of $28.12 million. Sees Q3 eps 6-12 cents versus 14 cents. Sees FY08 EPS 68-74 cents versus 92 cents.

Hanger Orthopedic Group (NYSE: HGR) 4.7% HIGHER; reports Q2 EPS of $0.25, 5 cents better than the analyst estimate of $0.20. Revenues for the quarter were $181.2 million, versus the consensus of $171.13 million. Sees FY08 80-82 cents versus 76 cents. Sees FY08 revenue $680-$690 million versus $679.7.

Centex Corporation (NYSE: CTX) 4.7% HIGHER; reports a Q2 loss of $1.36, versus the analyst estimate of ($1.11). Revenues for the quarter were $1.13 billion, versus the consensus of $1.30 billion.

Advent Software (Nasdaq: ADVS) 4.5% HIGHER; reports Q2 EPS of $0.22, 12 cents better than the analyst estimate of $0.10. Revenues for the quarter were $64 million, versus the consensus of $62 million. Sees Q3 revenues between $64 - $66 million vs. $63.39 million consensus. Sees FY revenues between $254-$258 million and non-GAAP EPS between $0.91 - $1.03 vs. $254.33 million and $0.58 consensus, respectively.

Electronic Arts (Nasdaq: ERTS) 4% LOWER; reports a Q1 loss of $0.42 ex-items, versus the analyst estimate of ($0.33). Revenues for the quarter were $609 million, versus the consensus of $639.85 million. Sees FY09 EPS $1.30 to $1.70 versus $1.59 per share

Viacom (NYSE: VIA) 3.7% LOWER; reports Q2 EPS of $0.64, 5 cents better than the analyst estimate of $0.59. Revenues for the quarter were $3.86 billion, versus the consensus of $3.55 billion.

CommScope (NYSE: CTV) 3.7% LOWER; reports Q2 EPS of $1.00, 13 cents better than the analyst estimate of $0.87. Revenues for the quarter were $1.09 billion, versus the consensus of $1.08 billion. Sees Q3 revenues $1.08-$1.13 billion versus $1.13 billion. Sees $4.15-$4.25 billion versus 4.28 billion.

Silicon Motion (Nasdaq: SIMO) 3% LOWER; reports Q2 EPS of $0.26, 18 cents below the analyst estimate of $0.44. Revenues for the quarter were $48.6 million, versus the consensus of $53.30 million. Sees FY08 revenue $200 to $205 million, down from prior guidance $225-$235 million, consensus is $233 million. Sees FY08 EPS $1.30 to $1.40, versus prior guidance $1.95 to $2.05, consensus is $2.00.

Get This Report E-Mailed To You Daily and Much, Much More With StreetInsider.com Premium - FREE TRIAL

Related Categories

Special Reports

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?